WHO WE ARE

Our Focus & Vision

InFocus Clinical was born out of the visible disconnect between large, traditional CROs and their clients. We have worked for and with large and small biotech and pharma sponsors as well as CROs large and small. InFocus Clinical was founded with the centennial mission of coalescing the best and brightest clinical research professionals and proven leaders in retina vitreous development to advance ophthalmology therapeutic development.

Supported and co-founded by USRetina, the largest consortium of retina specialists, we answered the call of delivering a team exclusively dedicated to advancing ophthalmology development. Based on our tremendously diverse industry experience, we offer an integrated vision with an emphasis on using the most committed and experienced clinical research professionals in the clinical research industry to provide quality, timely, flexible execution second to none. We understand that only a therapeutically focused model – with specialized staff training and expertise – delivers the quality, efficiency, respect and results every company and every product deserves.

OUR ADVANTAGE

The InFocus Clinical Advantage

The unique positioning of InFocus Clinical, as founded by USRetina, ensures rapid integration of your protocol with KOLs, key enrolling sites and, ultimately, the greatest possible exposure of your product throughout development. The InFocus Scientific Advisory Board is comprised of the most proven and respected retina specialists. The fact InFocus is not just therapeutically aligned but focused, with proprietary and unprecedented staff training, ensures our staff are the most knowledgeable and your product is developed with superior efficiency and commitment.

With all of these elements, InFocus Clinical assures an unparalleled quality, integrity, flexibility, knowledge, experience, insight and responsiveness to the needs of a protocol or drug development program large or small.

 
 
PRESIDENT AND CEO

Brad Doerschuk

A passionate, visionary, proven leader at all levels of clinical development, Brad founded PharmaMed Research in 2001 prior to co-founding InFocus Clinical in partnership with USRetina – the leading alliance of retina specialists. A 2012 PharmaVoice 100 recipient with a 20 year history of leadership in development of products including Tamiflu, Pegasys, Provenge and many others, Brad has a proven ability to connect with all levels of a clinical development program. Brad has a penchant for merging best practices to forge uncanny efficiency, teamwork, commitment, superior trial enrollment and execution. Brad has led successful development programs with small, focused, single-compound companies as well as critical large-scale development programs with some of the largest pharmaceutical companies.



MEET THE TEAM

InFocus Management Team

The InFocus Management Team is comprised of the
most proven and respected CRO professionals.

Rich Miles

Chief Financial Officer

Rich brings InFocus vast experience and a career history of working with companies at all stages of growth – from $500,000 to $200 million in revenue. With over 30 years of experience as a CEO, COO, and CFO, Rich provides exceptional expertise in strategic and background in planning, budgeting and forecasting, as well as cash flow management. Rich has served two NYSE companies, one NASDAQ listed company, three startup companies, three turn-around situations, and several small middle market companies in their M&A activities. InFocus is blessed to have the guidance, input, expertise and leverage that Rich provides.

Lawrence Singerman, MD

Vice President of Medical Affairs

Dr. Singerman provides executive leadership and oversight of InFocus Clinical Research medical monitoring, advisory boards and therapeutic specialty training. Dr. Singerman completed his retinal training at the Wilmer Eye Institute and founded Retina Associates of Cleveland. He has been a principal investigator >150 clinical research trials, given >600 presentations at national and international courses and symposia on macular and retinal vascular disease, and authored over 370 publications. In 1977, Dr. Singerman founded the Macula Society. He is also a Charter Inductee of the Retina Hall of Fame. Dr. Singerman is Clinical Professor of Ophthalmology at Case Western Reserve University School of Medicine and at the Bascom Palmer Eye Institute of the University of Miami School of Medicine. He has received Lifetime Achievement Awards from the American Academy of Ophthalmology and the Diabetes Partnership of Cleveland. He was Vice-chair of the Council of the American Academy of Ophthalmology.

John Hedberg

Vice President, Strategic Development

John brings a vast and valuable background. As a former FDA investigator with 30+ years experience in clinical research and healthcare technology, John has extensive and broad expertise in Pharma, Biotech and Contract Research Organizations (CROs). As founder and CEO of a successful CRO specializing in eClinical technology solutions, John led the development of a first-in-class combination Electronic Data Capture (EDC) and Clinical Trial Management System (CTMS). In 2003, John’s company merged with a larger CRO and he groomed the new entity for sale to PRA Health Sciences in 2013. His extensive knowledge in regulatory compliance, enforcement policies, due diligence, mergers and acquisitions, sales and operations brings great value for InFocus and the clients we serve.

Matt Daiker

Vice President, Legal and Contracts

Matt brings a unique combination of legal experience to his VP role at InFocus Clinical Research. During his 15 years of practice prior to joining InFocus, Matt negotiated a wide array of contracts with numerous Fortune 50 companies and tried complex litigation matters to successful verdicts in both federal and state courts. He has significant business experience as well, assisting start-up organizations to successfully get their operations off the ground and helping long-established companies to modernize and flourish in an ever-evolving business world. Matt uses his wide breadth of legal experiences to manage all legal and contract matters with which InFocus Clinical Research encounters.

Ken Milstead

Vice President, Biostatistics and Data Management

Ken is one of the most respected, successful data management professionals in clinical research and development. With 29 years experience in the US, Canada, and Europe, including 26 years in phase I-IV clinical trials and registries the exposures Ken has are invaluable to our clinical development partners. In addition to expertise in all aspects of Clinical Data Management, Ken is also a SAS programmer, and manages EDC configuration, validation, and implementations. Ken has extensive experience with Electronic Data Capture (EDC) for clinical trials and registries using various software systems. Ken shares InFocus’ passion for helping companies get qualified new drugs and devices approved by the FDA and other regulatory agencies by helping them collect, clean, and report their data properly and efficiently.

Bob Keller

Director, Quality Assurance and Regulatory Affairs

Bob came to InFocus after a 30 year career in healthcare and clinical research, including over 15 years managing Phase I programs for Schering Plough. Bob drives the execution of global regulatory and quality assurance strategy, using creativity and innovation while balancing the business needs of InFocus with regulatory compliance. Bob’s extensive background and experience provides counsel to all InFocus senior management, training and interpretation of the FDA’s and other regulatory authorities’ feedback, policies and guidelines. Bob is responsible for the InFocus Quality Assurance Programs and ensures compliance with regulatory agencies and all applicable standards worldwide as well as applicable internal or external client SOPs.

The InFocus Scientific Advisory Board

The InFocus Scientific Advisory Board
is comprised of the most proven and respected retina specialists.



Meet the board →

Do we have your attention?

Get in touch with us to see how we can
help your company or product.


Get in touch →